as of 2019 - 05 - 07

22.C Safety, toxicological, and precedence of use issues

22.C Safety, toxicological, and precedence of use issues
In this chapter you will find answers to the following questions:

How can precedence of use be assessed for marketed excipients?

How can safety be assessed for a chemical to be used as new excipient?

A paid subscription is needed to login into the GMP Compliance Adviser. Click here for more information.

Username
Password
enlarge font size by using the short cut 'ctrl' and '+' (from IE 7, Firefox)